University of California, Los Angeles
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, Los Angeles sits in the top decile of US sponsors by registered trial count (#37 of 15,742 sponsors by registered trial count).
University of California, Los Angeles: 897 sponsored US clinical trials, 158 recruiting.
University of California, Los Angeles sponsors 897 registered US clinical trials on ClinicalTrials.gov, 158 of them currently recruiting, and 622 completed. 98 of these trials are in Phase 3-4 (later-stage) and 194 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 17 trials.
Top-decile sponsor footprint
University of California, Los Angeles ranks in the top decile of sponsors by registered trial count (#37 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
622 of 679 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
897 total, page 16 of 18
Effects of a Spiced Meat Patty on Inflammation in Men With Type 2 Diabetes
NCT01076829
Neurophysiologic Predictors of Outcome With rTMS Treatment of Major Depressive Disorder
NCT00956514
Effectiveness of Early Intervention in an Underserved Population
NCT01250938
Hepatitis B Virus (HBV) Prevention for Homeless at Risk for HBV/Hepatitis C Virus (HCV)/HIV
NCT00926146
HOPE (Harnessing Online Peer Education): Using Online Social Networks for HIV Prevention and Testing
NCT01701206
Iyengar Yoga for Young People With Rheumatoid Arthritis
NCT01096823
Personalized Indicators for Predicting Response to SSRI Treatment in Major Depression (The PRISE-MD Study)
NCT00917059
Small Bowel Capsule Endoscopy Findings in Patients Receiving Cellcept®
NCT00652834
Mood and Diabetes Empowerment & Improvement Training
NCT02010684
Exercise Induced Pulmonary Hypertension in Systemic Sclerosis and Treatment With Ambrisentan
NCT01051960
Earlier Intraocular Pressure Control After Ahmed Glaucoma Valve Implantation for Glaucoma
NCT00869141
Study of Recently HIV Infected Men and Transmission Behaviors
NCT01201083
Fenzian Asthma Multicenter Outcomes Study
NCT00784758
Non-invasive Measures of Effects of Xolair in Asthma
NCT00784485
Study of Medical Treatment for Methamphetamine Addiction
NCT00833443
An HIV Intervention for Black Men at Risk - The Enhanced Sexual Health Intervention for Men (ES-HIM)
NCT01641146
A Controlled Study of Community-based Exercise Training in Patients With Moderate COPD
NCT01985529
The Role of Pulsatile Insulin Secretion (A Study Investigating the Effects of Partial Pacreatectomy on Glucose Metabolism)
NCT00841867
Sleep and Immunity in Rheumatoid Arthritis : Remicade Substudy
NCT00948610
Rapid Opiate Detoxification and Naltrexone Induction Using Buprenorphine - 2
NCT00000299
Examining Long-Term Effects and Neural Mediators of Behavioral Treatments for Social Anxiety Disorder
NCT00872820
Repetitive Transcranial Magnetic Stimulation (TMS) for Progressive Supranuclear Palsy and Corticobasal Degeneration
NCT01174771
Risperidone Treatment In Children With Autism Spectrum Disorder And High Levels Of Repetitive Behavior
NCT01171937
Randomized, Double-Blind Cross-Over Trial Of Buprenorphine and Low-Dose Naloxone Versus Buprenorphine
NCT00679458
Cognitive Behavioral Therapy for Core Autism Symptoms in School-Aged Children: A Randomized, Controlled Trial
NCT00789932
Raltegravir Therapy for Women With HIV and Fat Accumulation
NCT00656175
Pediatric Bipolar Disorder Study at UCLA
NCT00961935
Improving Diabetes Care With Patient Decision Aids - A Trial in Community-based Primary Care
NCT00668590
Brain Deficits in HIV/HCV Coinfected People Before and After Anti-HCV Therapy
NCT00747539
Proteomic Analysis Reveals Innate Immune Activity In Intestinal Transplant Dysfunction
NCT01140152
An Assessment of the Safety of Varenicline in Methamphetamine-dependent Volunteers
NCT00713479
Cognitive Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder
NCT00748761
Modafinil Effects on Cognition in Schizophrenia Patients
NCT00711464
Using Clonidine to Improve Leg Weakness in People With Heart Failure
NCT00858845
Activating Seniors to Improve Chronic Disease Care
NCT00651495
An Arts Intervention for Drug-Using Homeless Youth
NCT00862238
Study of the Effects of an Antidepressant Medication and Placebo on the Brain Functioning of Normal Subjects
NCT00634283
Effectiveness of Methylphenidate in Improving Cognition and Function in Older Adults With Depression
NCT00602290
Mindfulness Meditation in Older Adults
NCT01532596
Family Focused Treatment of Pediatric Obsessive Compulsive Disorder
NCT01409642
Treating H. Pylori in Parkinson's Patients With Motor Fluctuations
NCT00664209
Youth Smoking Cessation: Therapy +/- "The Patch"
NCT00631020
Comparison Endotracheal Cardiac Output Monitor (ECOM) to a Standard Device in Measuring Heart Blood Volume
NCT00883857
Reducing Health Risk Behavior and Improving Health in Adolescents With Depression
NCT00461539
Primary Care and Adolescent Immunization for Rochester
NCT00581347
Adjunctive Transcranial Direct Current Stimulation for Cognition in Major Depression
NCT00760097
POL and Access Intervention to Reduce HIV Stigma Among Service Providers in China
NCT01052415
Motivational Therapy for Substance Users With Depression
NCT01189799
Assisting HIV-infected Mothers in Disclosing Their Serostatus to Their Children
NCT00429546
A Study Using The Experimental Drug Called Imatinib (Gleevec) in Subjects With Systemic Sclerosis
NCT00512902
What is open in the University of California, Los Angeles pipeline
158 recruiting of 897 indexed (18% open); 622 completed (69%).
Phase mix: 98 late (III/IV) vs 194 early (I/II) (early-phase heavy).
Top condition: Depression (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, Los Angeles: open-pipeline peers nationwide
Peers matched on 897 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
University of California, Los Angeles sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 897 trials (± recruiting share)
- Indiana University · 890 trials · 18% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- University of Texas Southwestern Medical Center · 837 trials · 19% recruiting
Sponsors near 18% open enrollment (± trial volume)
- ConvaTec · 18% recruiting · 17 trials
- Endologix · 18% recruiting · 17 trials
- National Institute on Deafness and Other Communication Disorders (NIDCD) · 18% recruiting · 34 trials
- NICHD Pelvic Floor Disorders Network · 18% recruiting · 17 trials
Related
What to do with this University of California, Los Angeles page
897 registered trials is a research-attention snapshot, not an endorsement of University of California, Los Angeles or any single study.
- 158 of University of California, Los Angeles's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition University of California, Los Angeles studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, Los Angeles pipeline card: 897 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.